triple therapy
三联疗法
2025-06-05 22:47 浏览次数 4
三联疗法
triple therapy regimens三联方案
triple combination therapy三合一疗法
triple eradication therapy三联疗法根除治疗
triple intrathecal therapy三联鞘膜内疗法
triple-agent therapy三合一疗法
triple drug therapy三联方案
triple regimen therapy三联疗法
Triple Gene Therapy三元基因疗法
triple therapy consists of 7 to 14 days of the antibiotics amoxicillin and clarithromycin, taken in combination with an anti-acid pill known as a proton-pump inhibitor.
三联疗法一般为期7-14天,将联合使用抗生素阿莫西林和克拉霉素,同时结合使用抗酸药物ppi(质子泵抑制剂)。
conclusion: qingyouyangwei capsules combined with triple therapy can significantly improve the eradication rate of lip and remission rate of symptoms. it has safety and definite clinical efficacy.
结论:清幽养胃胶囊联合三联方案能提高单纯三联疗法幽门螺桿菌根除率,明显缓解患者临床癥状,安全有效。
but we know that triple therapy increases adverse effects.
但是,大家都知道三联疗法的副作用也增多。
however, from the cost-effectiveness point of view, the 10-day sequential therapy is more economical than the standard triple therapy for 10 days.
但从成本-效益角度来说,10天序贯疗法较10天标準三联疗法更为经济。
patients undergoing stent-based pci should be treated with triple therapy consisting of aspirin clopidogrel and warfarin.
植入支架的pci患者应该应用阿司匹林、氯吡格雷和华法林三联治疗。
abstr: objective: to explore the efficacy and safety of qjngyouyangwei capsules combined with triple therapy in treatment of helicobacter pylori (hp) associated gastritis.
文章摘要:目的:观察清幽养胃胶囊联合常规三联方案治疗慢性胃炎合并幽门螺桿菌感染的疗效及安全性。
therefore, this is the triple therapy that we use at our institution.
因此我们在临床实践中使用以上的三联疗法。
if we think of all of these agents being necessary we come into the field of triple therapy and obviously this is a form of treatment which could easily be complicated by bleeding.
若这些药物均为必要,就需进行三联抗栓治疗,显然这是一种易于并发出血的治疗形式。
objective to systematically assess the effectiveness and adverse reaction rates of levofloxacin ppi triple therapy in the treatment of helicobacter pylori(hp).
目的系统性评价左氧氟沙星和质子泵抑制剂(ppi)三联疗法治疗幽门螺桿菌(hp)的疗效和不良反应发生率。
in the newly updated aasld practice guideline for treatment of genotype 1 chronic hcv infection, triple therapy is recommended for both naive and treated genotype 1 chronic hcv infection.
最近更新的aasld指南指出针对慢性hcv感染基因1型初始治疗或再次治疗的患者都推荐采用三联疗法。
for that reason, we like to keep the triple therapy as short as possible.
基于此,应尽可能缩短三联治疗的时间。
in my opinion, it is not with triple therapy that we can solve this problem but with alternative antiplatelet agents.
我觉得,三重治疗并不能解决问题,而应该选择其他可选择的抗血小板药物。
incidentally, triple therapy has not improved outcomes for these patients but we anticipate there will be, from the results of ongoing clinical trials.
另外,三联疗法不能改善这些患者的转归,但从正在进行的临床试验的结果来看,我们估计其可以。
in some patients it is impossible so we should have triple therapy but shorten the triple therapy as much as possible, at least to one month then put the patient on double therapy.
部分患者可能并不能做到这一点,导致我们需要三重抗血栓治疗,但也应尽可能缩短三药联合治疗时间,最多使用1月后换成双重治疗。
objective:to compare cure rates and to do economic evaluation of using ppi triple regimen and bismuth based triple therapy for anti hp.
目的:对质子泵抑制剂三联与铋剂三联抗幽门螺桿菌根治率进行比较及对两类方法做经济评价。
to cut a long story short even for people with favorable il-28 genotypes, due to the advantages triple therapy offers should still be offered triple therapy.
由于三联疗法可以缩短疗程,因此,即使是携带有利的il28基因型的患者也应该采用三联疗法进行治疗。